LIXT
NASDAQ · Biotechnology
Lixte Biotechnology Holdings
$4.05
+0.12 (+3.05%)
Open$3.94
Previous Close$3.93
Day High$4.25
Day Low$3.94
52W High$8.38
52W Low$2.36
Volume—
Avg Volume477.8K
Market Cap125.36M
P/E Ratio—
EPS$-1.10
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.59M | 2.67M | 2.41M |
| Net Income | 404.7K | 492.8K | 436.5K |
| Profit Margin | 15.6% | 18.4% | 18.1% |
| EBITDA | 711.7K | 711.0K | 701.7K |
| Free Cash Flow | 315.8K | 252.8K | 287.8K |
| Rev Growth | +13.7% | +15.1% | +4.1% |
| Debt/Equity | 1.15 | 1.36 | 1.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |